Fuse Medical Inc Revenue Growth Rates (FZMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Fuse Medical Inc   (FZMD)
 

FZMD's Revenue Growth by Quarter and Year

Fuse Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FZMD Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 4.47
1st Quarter March 3.98
FY 8.45

FZMDs Annual Revenue
Fuse Medical Inc 's Revenue in the fiscal year 2022 $ 18.64 millions
Fuse Medical Inc 's Revenue in the fiscal year 2021 $ 20.41 millions
Fuse Medical Inc 's Revenue in the fiscal year 2020 $ 21.40 millions
Fuse Medical Inc 's Revenue in the fiscal year 2019 $ 22.90 millions
Fuse Medical Inc 's Revenue in the fiscal year 2018 $ 26.34 millions




FZMD Revenue second quarter 2023 Y/Y Growth Comment
Fuse Medical Inc reported decrease in Revenue in the second quarter 2023 by -4.31% to $ 4.47 millions, from the same quarter in 2022.
The decrease in the second quarter 2023 Fuse Medical Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 725.93%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 144 other companies have achieved higher Revenue growth. While Fuse Medical Inc ' s Revenue decline of -4.31% ranks overall at the positon no. 2669 in the second quarter 2023.


FZMD Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - -19.31 % -13.55 % -4.5 %
3rd Quarter September - 6.82 % -25.96 % 0.35 %
2nd Quarter June -4.31 % -17.64 % 41.4 % -21.06 %
1st Quarter March -12.53 % 2.48 % -4.31 % -2.73 %
FY   - -8.67 % -4.58 % -

Financial Statements
Fuse Medical Inc 's second quarter 2023 Revenue $ 4.47 millions FZMD's Income Statement
Fuse Medical Inc 's second quarter 2022 Revenue $ 4.67 millions Quarterly FZMD's Income Statement


FZMD Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 7.71 % 42.59 % 22.13 %
3rd Quarter September - -2.78 % -25.04 % 43.14 %
2nd Quarter June 12.28 % 2.64 % 27.7 % -13.58 %
1st Quarter March -18.61 % -24.92 % -36.66 % -36.78 %
FY (Year on Year)   - -8.67 % -4.58 % -


Back to FZMD Growth rate Comparisons >> Back to FZMD Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #145
Healthcare Sector #445
Overall #2669

Revenue Y/Y Growth Statistics
High Average Low
17311.02 % 725.93 % -75.71 %
(Dec 31 2017)   (Sep 30 2016)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #145
Healthcare Sector #445
Overall #2669
Revenue Y/Y Growth Statistics
High Average Low
17311.02 % 725.93 % -75.71 %
(Dec 31 2017)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fuse Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5854.21 % 163.77 % -76.45 %
(Dec 31 2017)  


FZMD's II. Quarter Q/Q Revenue Comment
Fuse Medical Inc achieved in the II. Quarter 2023 below company average Revenue rise of 12.28% quarter on quarter, to $ 4.47 millions.

Although the II. Quarter 2023 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 2.64% growth in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 56 other companies have achieved higher Revenue quarter on quarter growth. While Fuse Medical Inc 's Revenue growth quarter on quarter, overall rank is 976.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #57
Healthcare Sector #228
Overall #976
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #57
Healthcare Sector #228
Overall #976
Revenue Q/Q Growth Statistics
High Average Low
5854.21 % 163.77 % -76.45 %
(Dec 31 2017)  


FZMD's II. Quarter Q/Q Revenue Comment
Fuse Medical Inc achieved in the II. Quarter 2023 below company average Revenue rise of 12.28% quarter on quarter, to $ 4.47 millions.

II. Quarter 2023 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.64% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 56 other companies have achieved higher Revenue quarter on quarter growth. While Fuse Medical Inc 's Revenue growth quarter on quarter, overall rank is 976.


Fuse Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 17.88 $ 18.07 $ 18.64 $ 19.82 $ 19.53
Y / Y Revenue Growth (TTM) -8.48 % -11.95 % -8.67 % -7.26 % -14.55 %
Year on Year Revenue Growth Overall Ranking # 3240 # 2435 # 2793 # 2615 # 2061
Seqeuential Revenue Change (TTM) -1.1 % -3.06 % -5.92 % 1.46 % -4.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 2860 # 2482 # 2787 # 2085 # 1816


Cumulative Revenue growth Comment
Fuse Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Fuse Medical Inc 's annual Revenue decline would be -8.48% year on year to $18 millions.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2435 to 3240.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 466
Overall # 3240

Revenue TTM Y/Y Growth Statistics
High Average Low
6070.96 %
 626.24 %
-67.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 135
Sector # 421
S&P 500 # 2860
Cumulative Revenue growth Comment
Fuse Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2023. If the fiscal year would end in Jun 30 2023, Fuse Medical Inc 's annual Revenue drop would be -8.48% year on year to $18 millions.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2435 to 3240.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 466
Overall # 3240

Revenue TTM Y/Y Growth Statistics
High Average Low
6070.96 %
626.24 %
-67.47 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 135
Sector # 421
S&P 500 # 2860




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FZMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Fortrea Holdings Inc -0.01%$ -0.013 millions
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Procyon Corporation-0.59%$ -0.589 millions
Amedisys Inc-0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc -1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Procaps Group S a -2.10%$ -2.102 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Oncology inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
Nrc Health-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Omniab Inc -3.51%$ -3.514 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Vireo Growth Inc.-4.24%$ -4.237 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions


About Fuse Medical Inc Revenue Growth Rates (FZMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Fuse Medical Inc (CIK 319016).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-23-023606
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Fuse Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.